Literature DB >> 16126358

Determination of oleanolic acid in human plasma and study of its pharmacokinetics in Chinese healthy male volunteers by HPLC tandem mass spectrometry.

Min Song1, Tai-jun Hang, Ying Wang, Li Jiang, Xiao-luan Wu, Zhengxing Zhang, Jianping Shen, Yindi Zhang.   

Abstract

A highly selective and sensitive HPLC-ESI-MS-MS method was developed for the determination of oleanolic acid in human plasma. The oleanolic acid and glycyrrhetinic acid (internal standard) were recovered from plasma with ethyl acetate liquid-liquid extraction. The organic extracts were dried under a stream of warm nitrogen, reconstituted in mobile phase and injected into a Zorbax-Extend ODS analytical column (150 mm x 4.6 mm i.d., 5 microm), with the mobile phase consisting of methanol-ammonium acetate (32.5 mM) (85:15, v/v) pumped at a flow rate of 1.0 ml/min, and 30% of the eluent was split into a MS system with electrospray ionization tandem mass (ESI-MS-MS) detection in negative ion mode. The tandem mass detection was performed on a Finnigan Surveyor LC-TSQ Quantum Ultra AM tandem mass spectrometer operated in selected reaction monitoring mode. The parent to product ion combinations of m/z 455.4-->455.4 and 469.3-->425.2 at 38 V 1.5 mTorr Ar CID were used to quantify oleanolic acid and glycyrrhetinic acid, respectively. The assay was validated in the concentration range of 0.02-30.0 ng/ml for oleacolic acid when 0.5 ml of plasma was processed. The precision of the assay (expressed as relative standard deviation, R.S.D.%) was less than 15% at all concentrations levels within the tested range and adequate accuracy, and the limit of quantification was 0.02 ng/ml. The established method was applied for the pharmacokinetics study of oleanolic acid capsules in 18 healthy male Chinese volunteers with the mean values of C(max), T(max), AUC(0-48), AUC(0-infinity), t(1/2,) CL/F, and V/F of oleanolic acid after p.o. a single 40 mg dose obtained were 12.12 +/- 6.84 ng/ml, 5.2 +/- 2.9h, 114.34 +/- 74.87 ng h/ml, 124.29 +/- 106.77 ng h/ml, 8.73 +/- 6.11 h, 555.3 +/- 347.7 L/h, and 3371.1 +/- 1,990.1 L, respectively.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16126358     DOI: 10.1016/j.jpba.2005.06.034

Source DB:  PubMed          Journal:  J Pharm Biomed Anal        ISSN: 0731-7085            Impact factor:   3.935


  11 in total

1.  Oleanane triterpenoids in the prevention and therapy of breast cancer: current evidence and future perspectives.

Authors:  Nisha R Parikh; Animesh Mandal; Deepak Bhatia; Kodappully Sivaraman Siveen; Gautam Sethi; Anupam Bishayee
Journal:  Phytochem Rev       Date:  2014-12       Impact factor: 5.374

Review 2.  Oleanolic acid and its synthetic derivatives for the prevention and therapy of cancer: preclinical and clinical evidence.

Authors:  Muthu K Shanmugam; Xiaoyun Dai; Alan Prem Kumar; Benny K H Tan; Gautam Sethi; Anupam Bishayee
Journal:  Cancer Lett       Date:  2014-01-30       Impact factor: 8.679

3.  Formulation, biological and pharmacokinetic studies of sucrose ester-stabilized nanosuspensions of oleanolic Acid.

Authors:  Wenji Li; Surajit Das; Ka-yun Ng; Paul W S Heng
Journal:  Pharm Res       Date:  2011-04-09       Impact factor: 4.200

4.  Oleanolic acid induces relaxation and calcium-independent release of endothelium-derived nitric oxide.

Authors:  R Rodriguez-Rodriguez; E Stankevicius; M D Herrera; L Ostergaard; M R Andersen; V Ruiz-Gutierrez; U Simonsen
Journal:  Br J Pharmacol       Date:  2008-07-14       Impact factor: 8.739

5.  Formulation development and bioavailability evaluation of a self-nanoemulsified drug delivery system of oleanolic acid.

Authors:  Jia Xi; Qi Chang; Chak K Chan; Zhao Yu Meng; Geng Nan Wang; Jia Bei Sun; Yi Tao Wang; Henry H Y Tong; Ying Zheng
Journal:  AAPS PharmSciTech       Date:  2009-02-18       Impact factor: 3.246

Review 6.  Development and Evaluation of Oleanolic Acid Dosage Forms and Its Derivatives.

Authors:  Anjie Feng; Shanjing Yang; Yue Sun; Li Zhang; Fumin Bo; Lingjun Li
Journal:  Biomed Res Int       Date:  2020-11-25       Impact factor: 3.411

7.  Pentacyclic Triterpene Profile and Its Biosynthetic Pathway in Cecropia telenitida as a Prospective Dietary Supplement.

Authors:  Gustavo Gutiérrez; Laura Marcela Valencia; Deisy Giraldo-Dávila; Marianny Y Combariza; Elkin Galeano; Norman Balcazar; Aram J Panay; Alejandra Maria Jerez; Guillermo Montoya
Journal:  Molecules       Date:  2021-02-18       Impact factor: 4.411

Review 8.  Ursolic and Oleanolic Acids: Plant Metabolites with Neuroprotective Potential.

Authors:  Evelina Gudoityte; Odeta Arandarcikaite; Ingrida Mazeikiene; Vidmantas Bendokas; Julius Liobikas
Journal:  Int J Mol Sci       Date:  2021-04-27       Impact factor: 5.923

9.  Shenjinhuoxue Mixture Attenuates Inflammation, Pain, and Cartilage Degeneration by Inhibiting TLR-4 and NF-κB Activation in Rats with Osteoarthritis: A Synergistic Combination of Multitarget Active Phytochemicals.

Authors:  Xiaoqin Ma; Chenxia Hao; Zhaokang Zhang; Huiting Jiang; Weixia Zhang; Jingjing Huang; Xiaofei Chen; Wanhua Yang
Journal:  Oxid Med Cell Longev       Date:  2021-10-21       Impact factor: 6.543

10.  Enhancement of platelet aggregation by ursolic Acid and oleanolic Acid.

Authors:  Mikyung Kim; Chang-Ho Han; Moo-Yeol Lee
Journal:  Biomol Ther (Seoul)       Date:  2014-05       Impact factor: 4.634

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.